
Berkley Gryder, PhD
Berkley Gryder, PhD is a member of the Crazy 8 team that is targeting the biological underpinnings of pulmonary metastasis in osteosarcoma
At Case Western Reserve University School of Medicine, Dr. Gryder is a chemist who retrained as a molecular biologist and computer scientist. He is passionate about understanding how cancer cells control their genes, and developing new chemical strategies to stop cancer cell’s addiction to gene transcription. Along the way, he has proposed paradigm shifts and surprises that are explaining old conundrums. Recognizing that the “right” answer to a tough question is often out of reach with current tools, Dr. Gryder is always innovating techniques with an ultra-high level of spatial and temporal precision to study gene control/epigenetics.
The diagnosis will not change, but the prognosis will change, as these projects progress.
Berkley Gryder, PhD
ALSF grants funded across North America and Europe
ALSF-funded clinical trials annually